- ►diabetesjournals.org S Tanaka, T Endo, K Aida, H Shimura, N Yokomori, … - Diabetes care, 2004 - Am Diabetes Assoc RESULTS—The integrated values of serum C-peptide response during OGTT (ΣC-peptide) in
fulminant type 1 diabetes at onset, 1 year, and 2 years after onset were markedly lower than
those in acute-onset type 1 diabetes. None of the patients with fulminant type 1 diabetes ... Cited by 11 - Related articles - BL Direct - All 5 versions
F Furuya, S Amemiya, M Mochizuki, K Nakanishi, T … - Diabetes Care, 2004 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS — We analyzed basal and longitudinal changes of serum
C-peptide levels during a 75-g oral glucose tolerance test (OGTT) in 125 consecutively recruited
patients with type 1 diabetes including fulminant type 1 diabetes (n Related articles
[CITATION] Immunology and immunogenetics of type 1 diabetes in Japan
AF Bristow, RE Das - Journal of biological standardization, 1988 - ncbi.nlm.nih.gov Candidate preparations for international reference reagents for immunoassays of human proinsulin
and human insulin C-peptide were evaluated in an international collaborative study. With the
authorization of the Expert Committee on Biological Standardization of WHO, the ... Cited by 11 - Related articles
- ►diabetesjournals.org S Tanaka, T Kobayashi, K Nakanishi, R Koyama, M … - Diabetes Care, 2002 - Am Diabetes Assoc OBJECTIVE—Some type 1 diabetic patients have a distinct phenotype characterized by the absence
of pancreatic autoantibodies and fulminant clinical symptoms at onset, including marked
hyperglycemia, severe diabetic ketoacidosis, and normal to near-normal HbA 1c levels ... Cited by 49 - Related articles - BL Direct - All 5 versions
K Nakanishi, T Kobayashi, T Sugimoto, T Murase, T … - Diabetes Care, 1988 - Am Diabetes Assoc Diabetes Care Skip to main page content. Home; Current Issue; Archive; Contact;
Subscribe; Alerts; Help. rss feed. Search GO. Advanced Search ». User Name Password
Sign In. Add to CiteULike CiteULike; Add to Del.icio.us Del.icio ... Cited by 12 - Related articles - All 3 versions
R Kotani, M Nagata, A Imagawa, H Moriyama, H … - Diabetologia, 2004 - Springer Aims/hypothesis. Fulminant Type 1 diabetes is a novel subtype of Type 1 diabetes that involves
the abrupt onset of insulin-deficient hyperglycaemia. This sub- type appears to be non-autoimmune
because of the ab- sence of diabetes-related autoantibodies in the serum, and of insulitis ... Cited by 24 - Related articles - BL Direct - All 4 versions
